Stock Events

Stock Events

Medicure 

$0.75
3
+$0+0% Today

Statistics

Day High
0.96
Day Low
0.96
52W High
0.96
52W Low
0.46
Volume
-
Avg. Volume
-
Mkt Cap
7.83M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

2JunExpected
Q1 2024
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Next
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-4.68%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
31.12MRevenue
-1.46MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MCUJF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap191.53B
Amgen develops and produces medications in similar therapeutic areas as Medicure, including cardiovascular drugs.
Novartis
NVS
Mkt Cap293.34B
Novartis is a global healthcare company that manufactures drugs like Entresto, competing in the cardiovascular market.
Pfizer
PFE
Mkt Cap156.77B
Pfizer produces a range of cardiovascular treatments, directly competing with Medicure's heart health products.
Merck
MRK
Mkt Cap294.39B
Merck & Co. offers cardiovascular therapies, including Zetia and Vytorin, which compete in the same space as Medicure.
Bristol-Myers Squibb
BMY
Mkt Cap122.85B
Bristol-Myers Squibb produces cardiovascular drugs, competing directly with Medicure's product offerings.
Abbvie
ABBV
Mkt Cap368.57B
AbbVie, through its acquisition of Allergan, has expanded into cardiovascular treatments, competing with Medicure.
Astrazeneca
AZN
Mkt Cap317.5B
AstraZeneca has a strong portfolio in cardiovascular diseases, including drugs like Brilinta, competing with Medicure.
Lilly(Eli) &
LLY
Mkt Cap829.71B
Eli Lilly and Company competes in the cardiovascular market, which overlaps with Medicure's therapeutic focus.
GSK
GSK
Mkt Cap117.55B
GlaxoSmithKline produces medications for heart diseases, competing in the same therapeutic areas as Medicure.
Sanofi
SNY
Mkt Cap115.14B
Sanofi offers a range of cardiovascular treatments, directly competing with Medicure in this therapeutic area.

About

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing MC-1 for the treatment of PNPO deficiency; and TARDOXAL for neurological indications, such as Tardive Dyskinesia. It offers products through retail and mail order pharmacies. The company was founded in 1997 and is headquartered in Winnipeg, Canada.
Show more...
CEO
Dr. Albert David Friesen Ph.D.
Employees
23
Country
Canada
ISIN
CA58469E4085

Listings

MU
DE
NGQ1.MU
STU
DE
NGQ1.STU
V
CA
MPH.V
F
DE
NGQ1.F

0 Comments

Share your thoughts

FAQ

What is Medicure stock price today?▼
The current price of MCUJF is $0.75 USD — it has increased by +0% in the past 24 hours. Watch Medicure stock price performance more closely on the chart.
What is Medicure stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Medicure stocks are traded under the ticker MCUJF.
Is Medicure stock price growing?▼
MCUJF stock has risen by +0% compared to the previous week, the month change is a +20% rise, over the last year Medicure has showed a +45.45% increase.
What is Medicure market cap?▼
Today Medicure has the market capitalization of 7.83M
When is the next Medicure earnings date?▼
Medicure is going to release the next earnings report on June 02, 2026.
What is Medicure revenue for the last year?▼
Medicure revenue for the last year amounts to 31.12M USD.
What is Medicure net income for the last year?▼
MCUJF net income for the last year is -1.46M USD.
How many employees does Medicure have?▼
As of April 24, 2026, the company has 23 employees.
In which sector is Medicure located?▼
Medicure operates in the Health & Wellness sector.
When did Medicure complete a stock split?▼
The last stock split for Medicure was on November 02, 2012 with a ratio of 1:15.
Where is Medicure headquartered?▼
Medicure is headquartered in Winnipeg, Canada.